Diagnostic Challenges in Pediatric Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Abstract

This review highlights the most common presentations of demyelination of the central nervous system (CNS, termed acquired demyelinating syndrome) in children, the difficulty in determining whether the first episode represents a monophasic/transient illness or relapsing disease, and the potential underlying etiologies that must be considered, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and disorders associated with antibodies to myelin oligodendrocyte glycoprotein (MOG) antibodies. The initial clinical and magnetic resonance imaging (MRI) features, as well as those observed over time, are highlighted, emphasizing the distinct and overlapping features of each of these disorders.

Keywords

acquired demyelinating syndrome - pediatric - multiple sclerosis - neuromyelitis optic spectrum disorder - AQP4 - MOG

• References

• 1 Krupp LB, Tardieu M, Amato MP. , et al; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19 (10) 1261-1267
• 2 Banwell B, Kennedy J, Sadovnick D. , et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009; 72 (03) 232-239
• 3 Polman CH, Reingold SC, Banwell B. , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69 (02) 292-302
• 4 Wingerchuk DM, Banwell B, Bennett JL. , et al; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85 (02) 177-189
• 5 Ramanathan S, Dale RC, Brilot F. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 2016; 15 (04) 307-324
• 6 Rostasy K, Bajer-Kornek B, Venkateswaran S, Hemingway C, Tardieu M. Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders. Neurology 2016; 87 (09) (Suppl. 02) S28-S37
• 7 O'Mahony J, Shroff M, Banwell B. Mimics and rare presentations of pediatric demyelination. Neuroimaging Clin N Am 2013; 23 (02) 321-336
• 8 Chitnis T. Pediatric demyelinating diseases. Continuum (Minneap Minn) 2013; 19 (4 Multiple Sclerosis): 1023-1045
• 9 Yeh EA, Chitnis T, Krupp L. , et al; US Network of Pediatric Multiple Sclerosis Centers of Excellence. Pediatric multiple sclerosis. Nat Rev Neurol 2009; 5 (11) 621-631
• 10 Miller DH, Weinshenker BG, Filippi M. , et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008; 14 (09) 1157-1174
• 11 Vanderver A. Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease. Curr Neurol Neurosci Rep 2005; 5 (02) 110-118
• 12 Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008; 65 (06) 727-732
• 13 Bonhomme GR, Waldman AT, Balcer LJ. , et al. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology 2009; 72 (10) 881-885
• 14 Banwell B, Krupp L, Kennedy J. , et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007; 6 (09) 773-781
• 15 Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 2009; 15 (05) 627-631
• 16 Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009; 66 (01) 54-59
• 17 McDonald WI, Compston A, Edan G. , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50 (01) 121-127
• 18 Sadaka Y, Verhey LH, Shroff MM. , et al; Canadian Pediatric Demyelinating Disease Network. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol 2012; 72 (02) 211-223
• 19 Pohl D, Rostasy K, Reiber H, Hanefeld F. CSF characteristics in early-onset multiple sclerosis. Neurology 2004; 63 (10) 1966-1967
• 20 Bar-Or A. The immunology of multiple sclerosis. Semin Neurol 2008; 28 (01) 29-45
• 21 Mowry EM, Carey RF, Blasco MR. , et al. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One 2013; 8 (10) e75416
• 22 van Pelt ED, Mescheriakova JY, Makhani N. , et al. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology 2013; 81 (23) 1996-2001
• 23 Banwell B, Bar-Or A, Arnold DL. , et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10 (05) 436-445
• 24 Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000; 11 (02) 220-224
• 25 Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6 (09) 805-815
• 26 Lennon VA, Wingerchuk DM, Kryzer TJ. , et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364 (9451): 2106-2112
• 27 Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202 (04) 473-477
• 28 McKeon A, Lennon VA, Lotze T. , et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71 (02) 93-100
• 29 Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011; 77 (12) 1143-1148
• 30 Absoud M, Cummins C, Desai N. , et al. Childhood optic neuritis clinical features and outcome. Arch Dis Child 2011; 96 (09) 860-862
• 31 Verhey LH, Branson HM, Makhija M, Shroff M, Banwell B. Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study. Neuroradiology 2010; 52 (12) 1153-1162
• 32 Tenembaum S, Chitnis T, Ness J, Hahn JS. ; International Pediatric MS Study Group. Acute disseminated encephalomyelitis. Neurology 2007; 68 (16, Suppl 2) S23-S36
• 33 Absoud M, Lim MJ, Appleton R. , et al. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015; 86 (04) 470-472
• 34 Collongues N, Marignier R, Zéphir H. , et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology 2010; 75 (12) 1084-1088
• 35 Chitnis T, Ness J, Krupp L. , et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology 2016; 86 (03) 245-252
• 36 Lee DH, Metz I, Berthele A. , et al. Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology. Neuropathol Appl Neurobiol 2010; 36 (07) 685-687
• 37 Misu T, Höftberger R, Fujihara K. , et al. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 2013; 125 (06) 815-827
• 38 Yanagawa K, Kawachi I, Toyoshima Y. , et al. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology 2009; 73 (20) 1628-1637
• 39 Saini H, Rifkin R, Gorelik M. , et al. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. BMC Neurol 2013; 13: 104
• 40 Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010; 133 (Pt 2): 349-361
• 41 Saadoun S, Waters P, Owens GP, Bennett JL, Vincent A, Papadopoulos MC. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun 2014; 2: 35
• 42 Waters PJ, McKeon A, Leite MI. , et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012; 78 (09) 665-671 , discussion 669
• 43 Marignier R, Bernard-Valnet R, Giraudon P. , et al; NOMADMUS Study Group. Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology 2013; 80 (24) 2194-2200
• 44 Fernandez-Carbonell C, Vargas-Lowy D, Musallam A. , et al. Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 2016; 22 (02) 174-184
• 45 Hacohen Y, Absoud M, Deiva K. , et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm 2015; 2 (02) e81
• 46 Baumann M, Sahin K, Lechner C. , et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 2015; 86 (03) 265-272
• 47 Pröbstel AK, Dornmair K, Bittner R. , et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011; 77 (06) 580-588
• 48 Cobo-Calvo Á, Sepúlveda M, Bernard-Valnet R. , et al. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications. Mult Scler 2016; 22 (03) 312-319
• 49 Sepúlveda M, Armangué T, Sola-Valls N. , et al. Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 2016; 3 (03) e225
• 50 Höftberger R, Sepulveda M, Armangue T. , et al. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 2015; 21 (07) 866-874
• 51 Sato DK, Callegaro D, Lana-Peixoto MA. , et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82 (06) 474-481
• 52 Kitley J, Waters P, Woodhall M. , et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014; 71 (03) 276-283
• 53 Ketelslegers IA, Van Pelt DE, Bryde S. , et al. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort. Mult Scler 2015; 21 (12) 1513-1520